Legend Biotech (LEGN) Non-cash Items (2020 - 2022)

Legend Biotech (LEGN) has 6 years of Non-cash Items data on file, last reported at -$20.8 million in Q3 2025.

• Quarterly Non-cash Items rose 57.67% year-over-year to -$20.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$99.1 million (up 55.8% YoY) and the FY2022 annual result came in at -$402.5 million, down 11.37% from the prior year.
• Non-cash Items fell to -$20.8 million in Q3 2025, from $3.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $3.5 million in Q2 2025 to a low of -$402.5 million in Q4 2022.
• A 5-year average of -$103.2 million and a median of -$77.3 million in 2021 frame the typical range for Non-cash Items.
• Annual changes were most pronounced in 2023 — Non-cash Items slumped 72.52% — and 2025, when it soared 137.88%.
• Tracing LEGN's Non-cash Items over 5 years: stood at -$361.4 million in 2021, then retreated by 11.37% to -$402.5 million in 2022, then soared by 81.58% to -$74.2 million in 2023, then jumped by 33.73% to -$49.1 million in 2024, then jumped by 57.67% to -$20.8 million in 2025.
• The last three Non-cash Items figures came in at -$20.8 million (Q3 2025), $3.5 million (Q2 2025), and -$32.7 million (Q1 2025), per Business Quant data.